Amygdala FAAH and anandamide: Mediating protection and recovery from stress

Trends in Pharmacological Sciences

Volumn 34, Issue 11, 2013, Pages 637-644

  Gunduz Cinar, Ozge ^a   Hill, Matthew N ^b   McEwen, Bruce S ^c   Holmes, Andrew ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

2 AG; anxiety; depression; endocannabinoid; fear; post traumatic stress disorder

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABIS; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DRONABINOL; ENDOCANNABINOID; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; JNJ 5003; PF 04457845; UNCLASSIFIED DRUG;

ANXIETY; ANXIETY DISORDER; BASOLATERAL AMYGDALA; BINDING AFFINITY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME REGULATION; FEAR; GENETIC VARIABILITY; HUMAN; LONG TERM DEPRESSION; MOLECULAR DYNAMICS; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BLOCKING; REINFORCEMENT; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; STRESS;

2-AG; ANXIETY; DEPRESSION; ENDOCANNABINOID; FEAR; POST-TRAUMATIC STRESS DISORDER;

AMIDOHYDROLASES; AMYGDALA; ANIMALS; ANXIETY DISORDERS; ARACHIDONIC ACIDS; ENDOCANNABINOIDS; ENZYME INHIBITORS; HUMANS; POLYUNSATURATED ALKAMIDES; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 84887406857     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2013.08.008     Document Type: Review

References (121)

1. S.K. Aggarwal Medicinal use of cannabis in the United States: historical perspectives, current trends, and future directions J. Opioid Manag. 5 2009 153 168
2. I. Katona, and T.F. Freund Multiple functions of endocannabinoid signaling in the brain Annu. Rev. Neurosci. 35 2012 529 558
3. J.T. Cheung Anxiety and mood disorders and cannabis use Am. J. Drug Alcohol Abuse 36 2010 118 122
4. N.T. Van Dam Characteristics of clinically anxious versus non-anxious regular, heavy marijuana users Addict. Behav. 37 2012 1217 1223
5. V. Agosti Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence Am. J. Drug Alcohol Abuse 28 2002 643 652
6. H. Thomas Psychiatric symptoms in cannabis users Br. J. Psychiatry 163 1993 141 149
7. L.F. Fabre, and D. McLendon The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety J. Clin. Pharmacol. 21 1981 377S 382S
8. G.A. Fraser The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD) CNS Neurosci. Ther. 15 2009 84 88
9. F.A. Moreira, and C.T. Wotjak Cannabinoids and anxiety Curr. Top. Behav. Neurosci. 2 2010 429 450
10. R. Mechoulam, and L.A. Parker The endocannabinoid system and the brain Annu. Rev. Psychol. 64 2013 21 47
11. V. Di Marzo, and L. De Petrocellis Why do cannabinoid receptors have more than one endogenous ligand? Philos. Trans. R. Soc. Lond. B: Biol. Sci. 367 2012 3216 3228
12. J.D. Buckner Problematic alcohol and cannabis use among young adults: the roles of depression and discomfort and distress tolerance Addict. Behav. 32 2007 1957 1963
13. V. Micale Endocannabinoid system and mood disorders: priming a target for new therapies Pharmacol. Ther. 138 2012 18 37
14. K. Mackie Distribution of cannabinoid receptors in the central and peripheral nervous system Handb. Exp. Pharmacol. 168 2005 299 325
15. J.P. Gong Cannabinoid CB2 receptors: immunohistochemical localization in rat brain Brain Res. 1071 2006 10 23
16. 2 receptors modulate cocaine's actions in mice Nat. Neurosci. 14 2011 1160 1166
17. R. Nyilas Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals J. Neurosci. 28 2008 1058 1063
18. M. Egertova Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: a new perspective on N-acylethanolamines as neural signaling molecules J. Comp. Neurol. 506 2008 604 615
19. I. Katona Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission J. Neurosci. 21 2001 9506 9518
20. A.I. Gulyas Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala Eur. J. Neurosci. 20 2004 441 458
21. A.J. McDonald, and F. Mascagni Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons Neuroscience 107 2001 641 652
22. T.S. Ramikie, and S. Patel Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress Neuroscience 204 2012 38 52
23. S.C. Azad Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala Learn. Mem. 15 2008 143 152
24. M.H. Rhee Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes J. Neurochem. 71 1998 1525 1534
25. J. Guo, and S.R. Ikeda Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons Mol. Pharmacol. 65 2004 665 674
26. 2+ channels in endocannabinoid-mediated long-term depression in the nucleus accumbens Neuropharmacology 54 2008 87 94
27. W. Twitchell Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons J. Neurophysiol. 78 1997 43 50
28. A. Cannich CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice Learn. Mem. 11 2004 625 632
29. B.D. Heifets Interneuron activity controls endocannabinoid-mediated presynaptic plasticity through calcineurin Proc. Natl. Acad. Sci. U.S.A. 105 2008 10250 10255
30. R. Mechoulam Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem. Pharmacol. 50 1995 83 90
31. E. Ryberg The orphan receptor GPR55 is a novel cannabinoid receptor Br. J. Pharmacol. 152 2007 1092 1101
32. P.M. Zygmunt Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 400 1999 452 457
33. D. Smart The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1) Br. J. Pharmacol. 129 2000 227 230
34. D. Melck Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors Biochem. Biophys. Res. Commun. 262 1999 275 284
35. A.C. Howlett Efficacy in CB1 receptor-mediated signal transduction Br. J. Pharmacol. 142 2004 1209 1218
36. M. Glass, and C.C. Felder Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor J. Neurosci. 17 1997 5327 5333
37. B. Bosier Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities Biochem. Pharmacol. 80 2010 1 12
38. N. Puente Polymodal activation of the endocannabinoid system in the extended amygdala Nat. Neurosci. 14 2011 1542 1547
39. L. Facci Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide Proc. Natl. Acad. Sci. U.S.A. 92 1995 3376 3380
40. W.A. Devane Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949
41. V. Natarajan Catabolism of N-acylethanolamine phospholipids by dog brain preparations J. Neurochem. 42 1984 1613 1619
42. N. Ueda Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide J. Biol. Chem. 270 1995 23823 23827
43. F. Desarnaud Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization J. Biol. Chem. 270 1995 6030 6035
44. B.F. Cravatt Chemical characterization of a family of brain lipids that induce sleep Science 268 1995 1506 1509
45. B.F. Cravatt Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 384 1996 83 87
46. K. Tsou Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry Neurosci. Lett. 254 1998 137 140
47. K. Kamprath Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala Neuropsychopharmacology 36 2011 652 663
48. S.C. Azad Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse Learn. Mem. 10 2003 116 128
49. M.R. Domenici Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission J. Neurosci. 26 2006 5794 5799
50. O. Gunduz-Cinar Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity Mol. Psychiatry 18 2013 813 823
51. S.C. Azad Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling J. Neurosci. 24 2004 9953 9961
52. J.L. Blankman, and B.F. Cravatt Chemical probes of endocannabinoid metabolism Pharmacol. Rev. 65 2013 849 871
53. B.B. Gorzalka Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders Neurosci. Biobehav. Rev. 32 2008 1152 1160
54. J. Kim, and B.E. Alger Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses Nat. Neurosci. 13 2010 592 600
55. K. Ahn Enzymatic pathways that regulate endocannabinoid signaling in the nervous system Chem. Rev. 108 2008 1687 1707
56. T. Jourdan Endocannabinoid-activated Nlrp3 inflammasome in infiltrating macrophages mediates β-cell loss in type 2 diabetes Nat. Med. 19 2013 1132 1140
57. S. Patel Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala Neuropsychopharmacology 34 2009 2699 2709
58. M.N. Hill Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis Neuropsychopharmacology 34 2009 2733 2745
59. D.J. Rademacher Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice Neuropharmacology 54 2008 108 116
60. S. Patel Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling Eur. J. Neurosci. 21 2005 1057 1069
61. S. Patel Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala Neuropsychopharmacology 30 2005 497 507
62. F.J. Meye Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity Mol. Psychiatry 2013 10.1038/mp.2012.145
63. R.J. Newsom Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats Neuroscience 204 2012 64 73
64. 1 inverse agonist AM251 potentiates the anxiogenic activity of urocortin I in the basolateral amygdala Neuropharmacology 62 2012 192 199
65. E. Ganon-Elazar, and I. Akirav Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance J. Neurosci. 29 2009 11078 11088
66. J. Haller Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats Psychopharmacology (Berl.) 204 2009 607 616
67. M.N. Hill Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output J. Neurosci. 30 2010 14980 14986
68. M.N. Hill Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure Mol. Psychiatry 2013 10.1038/mp.2012.90
69. C.G. Reich Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats Behav. Brain Res. 203 2009 264 269
70. A. Vyas Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons J. Neurosci. 22 2002 6810 6818
71. R. Mitra Stress duration modulates the spatiotemporal patterns of spine formation in the basolateral amygdala Proc. Natl. Acad. Sci. U.S.A. 102 2005 9371 9376
72. M. Padival Effects of repeated stress on excitatory drive of basal amygdala neurons in vivo Neuropsychopharmacology 38 2013 1748 1762
73. S. Rossi Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition Mol. Pharmacol. 78 2010 260 268
74. M.N. Hill Endogenous cannabinoid signaling is essential for stress adaptation Proc. Natl. Acad. Sci. U.S.A. 107 2010 9406 9411
75. J.J. Sumislawski Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation Neuropsychopharmacology 36 2011 2750 2761
76. S.G. Kinsey Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay Pharmacol. Biochem. Behav. 98 2011 21 27
77. A. Busquets-Garcia Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses Biol. Psychiatry 70 2011 479 486
78. N.R. Sciolino Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats Pharmacol. Res. 64 2011 226 234
79. C.A. Orsini, and S. Maren Neural and cellular mechanisms of fear and extinction memory formation Neurosci. Biobehav. Rev. 36 2012 1773 1802
80. C. Herry Neuronal circuits of fear extinction Eur. J. Neurosci. 31 2010 599 612
81. H.C. Lin Effects of intra-amygdala infusion of CB1 receptor agonists on the reconsolidation of fear-potentiated startle Learn. Mem. 13 2006 316 321
82. P. Campolongo Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory Proc. Natl. Acad. Sci. U.S.A. 106 2009 4888 4893
83. S.R. Laviolette, and A.A. Grace Cannabinoids potentiate emotional learning plasticity in neurons of the medial prefrontal cortex through basolateral amygdala inputs J. Neurosci. 26 2006 6458 6468
84. H. Tan Cannabinoid transmission in the basolateral amygdala modulates fear memory formation via functional inputs to the prelimbic cortex J. Neurosci. 31 2011 5300 5312
85. H. Tan Integrated cannabinoid CB1 receptor transmission within the amygdala-prefrontal cortical pathway modulates neuronal plasticity and emotional memory encoding Cereb. Cortex 20 2010 1486 1496
86. G. Marsicano The endogenous cannabinoid system controls extinction of aversive memories Nature 418 2002 530 534
87. A. Suzuki Memory reconsolidation and extinction have distinct temporal and biochemical signatures J. Neurosci. 24 2004 4787 4795
88. J.P. Chhatwal Functional interactions between endocannabinoid and CCK neurotransmitter systems may be critical for extinction learning Neuropsychopharmacology 34 2009 509 521
89. F.A. Pamplona The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats Psychopharmacology (Berl.) 188 2006 641 649
90. H.C. Lin The role of prefrontal cortex CB1 receptors in the modulation of fear memory Cereb. Cortex 19 2009 165 175
91. 1 receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats Eur. J. Neurosci. 26 2007 2643 2653
92. D.P. Finn Evidence for differential modulation of conditioned aversion and fear-conditioned analgesia by CB1 receptors Eur. J. Neurosci. 20 2004 848 852
93. W. Plendl, and C.T. Wotjak Dissociation of within- and between-session extinction of conditioned fear J. Neurosci. 30 2010 4990 4998
94. K. Kamprath Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes J. Neurosci. 26 2006 6677 6686
95. F.A. Pamplona Short- and long-term effects of cannabinoids on the extinction of contextual fear memory in rats Neurobiol. Learn. Mem. 90 2008 290 293
96. J.P. Chhatwal Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear Neuropsychopharmacology 30 2005 516 524
97. A. Izquierdo Brief uncontrollable stress causes dendritic retraction in infralimbic cortex and resistance to fear extinction in mice J. Neurosci. 26 2006 5733 5738
98. L. de Oliveira Alvares Opposite action of hippocampal CB1 receptors in memory reconsolidation and extinction Neuroscience 154 2008 1648 1655
99. C.A. Rabinak Cannabinoid facilitation of fear extinction memory recall in humans Neuropharmacology 64 2013 396 402
100. G. Godlewski Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects Chem Biol. 17 2010 1256 1266
101. M.C. Camp Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes Neuropsychopharmacology 37 2012 1534 1547
102. C. Herry Switching on and off fear by distinct neuronal circuits Nature 454 2008 600 606
103. A. Holmes Chronic alcohol remodels prefrontal neurons and disrupts NMDAR-mediated fear extinction encoding Nat. Neurosci. 15 2012 1359 1361
104. L.V. Panlilio Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction Pharmacol. Ther. 138 2013 84 102
105. E. Ganon-Elazar, and I. Akirav Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress Neuropsychopharmacology 37 2009 456 466
106. E. Ganon-Elazar, and I. Akirav Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit Psychoneuroendocrinology 38 2013 1675 1687
107. A. Neumeister Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study Mol. Psychiatry 18 2013 1034 1040
108. J.Z. Long Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects Nat. Chem. Biol. 5 2009 37 44
109. A.H. Lichtman Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo J. Pharmacol. Exp. Ther. 302 2002 73 79
110. J.E. Schlosburg Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system Nat. Neurosci. 13 2010 1113 1119
111. C.J. Riebe Estrogenic regulation of limbic cannabinoid receptor binding Psychoneuroendocrinology 35 2010 1265 1269
112. M.N. Hill Estrogen recruits the endocannabinoid system to modulate emotionality Psychoneuroendocrinology 32 2007 350 357
113. C. Scorticati The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen Proc. Natl. Acad. Sci. U.S.A. 101 2004 11891 11896
114. G.Z. Huang, and C.S. Woolley Estradiol acutely suppresses inhibition in the hippocampus through a sex-specific endocannabinoid and mGluR-dependent mechanism Neuron 74 2012 801 808
115. N.S. Waleh Transcriptional regulation of the mouse fatty acid amide hydrolase gene Gene 291 2002 203 210
116. J.M. Flanagan The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction Hum. Genet. 120 2006 581 588
117. J.C. Sipe Biomarkers of endocannabinoid system activation in severe obesity PLoS ONE 5 2010 e8792
118. K.P. Chiang Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use Hum. Mol. Genet. 13 2004 2113 2119
119. A.R. Hariri Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function Biol. Psychiatry 66 2009 9 16
120. A. Conzelmann A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional-motivational reactivity Psychopharmacology (Berl.) 224 2012 573 579
121. L. Depoy Chronic alcohol produces neuroadaptations to prime dorsal striatal learning Proc. Natl. Acad. Sci. U.S.A. 110 2013 14783 14788